Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peter Jenner

3PUBLICATIONS

4CO-AUTHORS

Basic pharmacologyPharmaceutical delivery technologiesClinical pharmacology and therapeutics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 15, 2025

Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptors.

Brittney Yegla, Jonathan Rubin, Mindy Grall

|Sep 02, 2025

COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion.

Peter Jenner, Dag Nyholm

|Jul 27, 2023

Stalevo<sup>®</sup> : A pioneering treatment for OFF periods in Parkinsons disease.

Peter Jenner

Pageof 1

Frequent Collaborators

1 joint publications

Dag Nyholm

1 joint publications

Jonathan Rubin

1 joint publications

Mindy Grall

1 joint publications

Andrea Formella

Frequent Collaborators

1 joint publications

Dag Nyholm

1 joint publications

Jonathan Rubin

1 joint publications

Mindy Grall

1 joint publications

Andrea Formella

Top Related Videos

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Published on : Mar 22, 2024

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on : Apr 29, 2007

See more related videos

Top Related Videos

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Published on : Mar 22, 2024

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on : Apr 29, 2007

See more related videos